Studies showed a clear link between mutations in CDKN1A and SREBF1 and the risk of developing NAFLD [22, 23] strengthening the involvement of these genes in diabetic fatty liver. Here, CDKN1A is linked to metabolic dysfunction-associated steatotic liver disease.